Nigeria misses out as 18m doses of first-ever malaria vaccine arrive in Africa – Newstrends
Connect with us

Health

Nigeria misses out as 18m doses of first-ever malaria vaccine arrive in Africa

Published

on

Anti-malaria vaccine

Nigeria misses out as 18m doses of first-ever malaria vaccine arrive in Africa

18 million doses of the first-ever malaria vaccine (RTS,S/AS01) will be given to 12 nations in various parts of Africa between 2023 and 2025.

This was revealed on Wednesday in a joint press statement by GAVI, the Vaccine Alliance, World Health Organization and United Nation Children’s Fund.

The RTS,S/AS01 vaccine is the first vaccine recommended for use by the World Health Organisation to prevent malaria in children in areas of moderate to high malaria transmission.

“Since 2019, Ghana, Kenya, and Malawi have been delivering the malaria vaccine through the Malaria Vaccine Implementation Programme, coordinated by WHO and funded by Gavi, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and Unitaid.

“The RTS,S/AS01 vaccine has been administered to more than 1.7 million children in Ghana, Kenya, and Malawi since 2019 and has been shown to be safe and effective, resulting in a substantial reduction in severe malaria and a fall in child deaths. At least 28 African countries have expressed interest in receiving the malaria vaccine.

READ ALSO:

“In addition to Ghana, Kenya, and Malawi, the initial 18 million dose allocation will enable nine more countries, including Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone, and Uganda, to introduce the vaccine into their routine immunization programmes for the first time, ” the statement read in part.

The statement noted that this allocation round makes use of the supply of vaccine doses available to Gavi via UNICEF, stating that the first doses of the malaria vaccine are expected to arrive in the selected countries during the last quarter of 2023 while the countries will start to roll them out by early 2024.

The allocations, according to the report, were made using the framework for allocating the limited supply of malaria vaccine, which prioritizes those doses to areas with the greatest need and the greatest risk of malaria disease and child mortality.

The Managing Director of Country Programmes Delivery at Gavi, Thabani Maphosa, said the vaccine has the potential to be very impactful in the fight against malaria, and when broadly deployed alongside other interventions, “it can prevent tens of thousands of future deaths every year.”

READ ALSO:

Maphosa added, “While we work with manufacturers to help ramp up supply, we need to make sure the doses that we do have are used as effectively as possible, which means applying all the learnings from our pilot programmes as we broaden out to a new total of 12 countries.”

Malaria remains one of Africa’s deadliest diseases, killing nearly half a million children each year under the age of five, and accounting for approximately 95 percent of global malaria cases and 96 per cent of deaths in 2021.

According to the UNICEF Associate Director of Immunisation, Ephrem Lemango, “Nearly every minute, a child under five years old dies of malaria.”

Lemango revealed that “For a long time, these deaths have been preventable and treatable; but the roll-out of this vaccine will give children, especially in Africa, an even better chance at surviving. As supply increases, we hope even more children can benefit from this life-saving advancement.”

The WHO Director of Immunisation, Vaccines and Biologicals, Dr Kate O’Brien, said the malaria vaccine was a breakthrough to improve child health and child survival; and families and communities.

“This first allocation of malaria vaccine doses are prioritised for children at the highest risk of dying of malaria. The high demand for the vaccine and the strong reach of childhood immunisation will increase equity in access to malaria prevention and save many young lives. We will work tirelessly to increase supply until all children at risk have access,” O’Brien said.

Nigeria misses out as 18m doses of first-ever malaria vaccine arrive in Africa

Health

Nido infant milk neither registered nor sold in Nigeria – NAFDAC

Published

on

Director-General of NAFDAC, Prof. Mojisola Adeyeye

Nido infant milk neither registered nor sold in Nigeria – NAFDAC

The National Agency for Food and Drug Administration and Control, NAFDAC, on Sunday declared that the Nido infant milk formula, alleged to contain sugar or honey, was not registered and sold in Nigeria.

The director-general of NAFDAC, Mojisola Adeyeye, made this known in a statement obtained by the News Agency of Nigeria in Lagos.

Mr Adeyeye said the attention of NAFDAC’s Management was drawn to an online publication alleging that one of the worlds largest consumer goods company added sugar and honey to infant milk and cereal products sold in many poorer countries, contrary to international guidelines aimed at preventing obesity and chronic diseases.

It stated that the online publication of April 17, 2024 was being circulated widely to the general public.

Mr Adeyeye said the report further stated that samples of baby food products sold in Asia, Africa and Latin America were tested and results revealed that sugar and honey were added in form of sucrose in samples of Nido and Cerelac.

“The Management of NAFDAC wishes to use this medium to reassure the public that the Agency exercises due regulatory diligence in the registration of infant and young children foods distributed and used in Nigeria.

“This is in line with relevant Codex Alimentarius international food standards (Codex) and more specifically, Nigerian Industrial Standards (NIS).

READ ALSO:

“This is applicable to all categories of infant and young children foods distributed by manufacturers, importers, and marketers of infant and young children foods operating within Nigeria.

“Regarding the mention of Nido follow-up milk formula in the publication, NAFDAC wishes to state that the product is not registered in Nigeria, is not known to the Agency and is not in circulation in Nigeria,” she stated.

According to Ms Adeyeye, the range of Nestle Cerelac infant cereals distributed in Nigeria are duly registered with NAFDAC in line with the Nigerian Industrial Standard for Foods for Infants and Young Children.

“Processed Cereal Based foods (NIS 256:2010) and the Codex Standard for Processed Cereal-based Foods for Infants and Young Children (CXS 74-1981 was adopted in 1981, revised in 2006, amended in 2017, 2019, and 2023), as well as the applicable NAFDAC regulations for compliance with safety, quality, and labelling requirements.

“Adequate, optimal nutrition during infancy and early childhood is essential to ensure the growth, health, and development of children to their full potential.

“The Codex Alimentarius Commission (CAC) implements the Joint FAO/WHO Food Standards Programme, developing international food standards, guidelines, and codes of practice with the mandate to protect the health of consumers and ensure fair international food trade.

“Nigeria (NAFDAC) is an active participant at these international food standards setting arena to contribute Nigerians positions during food standards development,” it said.

According to the statement, the Agency, on March 22 held a stakeholders engagement with members of the Association of Infant Food Manufacturers and Marketers in Nigeria, AIFMN, anchored by the Food Safety and Applied Nutrition, FSAN, Directorate, to further drive home the importance and special place of infant and young child nutrition.

Adeyeye reassured the public that the Agency was fully alive to her responsibilities of assuring the safety, wholesomeness and quality of infant and young children foods offered for sale in Nigeria in compliance with the relevant standards and regulations.

Nido infant milk neither registered nor sold in Nigeria – NAFDAC

NAN

Continue Reading

Health

5 reasons men need to eat pineapple before sexual intercourse

Published

on

5 reasons men need to eat pineapple before sexual intercourse

Sex ought to be an enjoyable activity, but many factors can get in the way of such enjoyment. Factors like low libido, lack of stamina, and erections can prevent such enjoyment. That’s why pineapples are so important. Many people believe it only benefits women, but it has many sexual benefits for men.

Sexual benefits of pineapple for men

Pineapples are rich in manganese, an antioxidant that fights free radicals and prevents cellular damage. A manganese deficiency can lead to diseases like heart disease and diabetes, which are linked to erectile dysfunction. However, adequate manganese intake can increase blood flow and prevent infertility.

Pineapples are rich in bromelain, which increases testosterone production and provides many sexual benefits in bed. This hormone regulates libido and encourages nitric oxide oxidation which makes men more sexually active.

READ ALSO:

Pineapples are also rich in vitamin C and thiamine which can increase low libido in men. Thiamine stimulates the development of sex hormones, and this is especially important when men can’t have an erection during sex.

Pineapple can help increase sexual stamina, especially for those who find themselves exhausted from sex. Sex requires endurance and stamina, with studies showing men can burn up to 101 calories in 30 minutes of sex. To enjoy bedroom fun without exercising, consider indulging in pineapples, which are rich in vitamins B1 and C, which can help increase sexual stamina.

Pineapple consumption before sex can enhance the taste of ejaculate by making it sweeter. This is due to the high levels of acid and sugar in pineapple, which make semen less bitter and more sweet. The primary benefit for partners is the added sweetness, in case they want to taste it.

Raw pineapple, rich in vitamin C, is an antioxidant that strengthens the immune system and prevents inflammation. Studies on rats have linked reduced inflammation to improved blood flow, which is important for sexual health.

This is because healthy blood flow is essential for achieving sexual arousal and erectile function for penetrative sex. This increased blood flow and higher blood pressure within the penis make the penis firm and erect.

Finally, a cup of pineapple or one pineapple finely chopped is enough; do not eat more than that, as it will have the opposite effect.

5 reasons men need to eat pineapple before sexual intercourse

Continue Reading

Health

NAFDAC alerts to counterfeit Tandak injection in Nigeria

Published

on

NAFDAC alerts to counterfeit Tandak injection in Nigeria

The National Drug Law Enforcement Agency (NAFDAC) has alerted Nigerians about the sale of counterfeit TANDAK injection 1.5g powder and water for injection, manufactured by Intracin Pharmaceuticals PVT. LTD C-1, B-53, G.I.D.C Estate, Nadiad- 387001, Gujarat, India.

A statement released by the agency on Wednesday, April 10, says the counterfeit product was discovered in Gombe State, Nigeria, and reported to the Agency by Marcson Healthcare Ltd. – the Marketing Authorisation Holder (MAH).

NAFDAC alerts Nigerians on the sale of counterfeit Tandak Injection in Nigeria

‘’Tandak® injection of 1.5g powder is a co-formulation of Ceftriaxone 1000mg and Sulbactam 500mg. It is prescribed for use in the treatment of various types of bacterial infections. It fights against micro organisms by preventing their growth, and further spread of the infection. Ceftriaxone+Sulbactam 1000mg/500mg Injection should only be administered under the supervision of a healthcare professional. the statement read

READ ALSO:

The illegal marketing of counterfeit medicines poses a risk to the health of people, since by not complying with the regulatory provisions, the safety, quality, and efficacy of the products are not guaranteed.

NAFDAC has directed all its Zonal Directors and State Coordinators to carry out surveillance and mop up the counterfeit products within the Zones and States.

Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322 or send an email to sf.alert@nafdac.gov.ng.

NAFDAC alerts to counterfeit Tandak injection in Nigeria

Continue Reading

Trending

Skip to content